Back to Search
WARREN KUPIN, MD
MD
Nephrology Physician
NPI: 1568408532IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
ME79060(FL)
CMS Specialties
PrimaryNEPHROLOGY
Education
MEDICAL COLLEGE OF WISCONSIN
Class of 1980
Research & Publications (17)
Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management.
PMID 19295312·Transplantation·2009
8-other
Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
PMID 18622280·Transplantation·2008
4-observational
Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-up.
PMID 18347528·Transplantation·2008
8-other
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis.
PMID 16570006·Transplantation·2006
2-rct
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
PMID 16123718·Transplantation·2005
3-trial
The use of Campath-1H as induction therapy in renal transplantation: preliminary results.
PMID 15316372·Transplantation·2004
3-trial
Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy.
PMID 15233820·Clin Transplant·2004
8-other
Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation.
PMID 15233817·Clin Transplant·2004
8-other
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.
PMID 14742990·Transplantation·2004
3-trial
A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
PMID 14742989·Transplantation·2004
3-trial
The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants.
PMID 14703925·Clin Transplant·2003
3-trial
The use of daclizumab, tacrolimus and mycophenolate mofetil in african-american and Hispanic first renal transplant recipients.
PMID 12859538·Am J Transplant·2003
8-other
Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.
PMID 12644172·Transplant Proc·2003
8-other
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.
PMID 12176508·Transplant Proc·2002
4-observational
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.
PMID 12176505·Transplant Proc·2002
3-trial
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
PMID 11965039·Transplantation·2002
8-other
Six-year clinical effect of donor bone marrow infusions in renal transplant patients.
PMID 11349712·Transplantation·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1450 NW 10TH AVE
MIAMI, FL 33136 - Phone
- (305) 243-6251
Quick Facts
- NPI
- 1568408532
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 17
Are you this provider?
Claim Your Profile